Anzeige
Mehr »
Freitag, 04.07.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PD78 | ISIN: BE0974340722 | Ticker-Symbol: 2SE
Frankfurt
04.07.25 | 08:01
1,332 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SEQUANA MEDICAL NV Chart 1 Jahr
5-Tage-Chart
SEQUANA MEDICAL NV 5-Tage-Chart
RealtimeGeldBriefZeit
1,4701,48012:46

Aktuelle News zur SEQUANA MEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
26.06.Sequana Medical NV: Transparency Notification from Shareholders184Transparency Notification from Shareholders Ghent, Belgium - 26 June 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of...
► Artikel lesen
17.06.Sequana Medical NV: Transparency Notification from Shareholders268Transparency Notification from Shareholders Ghent, Belgium - 17 June 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of...
► Artikel lesen
06.06.Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES337SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 6 June 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical")...
► Artikel lesen
SEQUANA MEDICAL Aktie jetzt für 0€ handeln
06.06.Sequana Medical NV: Transparency Notification from Shareholders435Transparency Notification from Shareholders Ghent, Belgium - 6 June 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of...
► Artikel lesen
27.05.Sequana Medical NV: Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders1.213Sequana Medical Secures Additional Convertible Financing of EUR 6.3 Million from SFPIM and Other Existing Shareholders Continued strong support from major shareholders alfapump® US commercial...
► Artikel lesen
22.05.Sequana Medical NV: Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders321Sequana Medical announces results of Annual and Extraordinary General Meetings of Shareholders Ghent, Belgium, 22 May 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or...
► Artikel lesen
14.05.Sequana Medical NV: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES295SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 14 May 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical")...
► Artikel lesen
08.05.Sequana Medical NV: Transparency Notification from Shareholders319Transparency Notification from Shareholders Ghent, Belgium - 8 May 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of drug-resistant...
► Artikel lesen
07.05.Sequana Medical NV: Sequana Medical Announces The Issuance Of A Subscription Request Notice Under The Share Subscription Facility Agreement With Gem317SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 7 May 2025 - Sequana Medical NV (Euronext Brussels:...
► Artikel lesen
28.04.Sequana Medical NV: Sequana Medical Announces New Share Capital Amount and New Number of Shares329SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 28 April 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical")...
► Artikel lesen
25.04.Sequana Medical NV: Transparency Notification from Shareholders291Transparency Notification from Shareholders Ghent, Belgium - 25 April 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of...
► Artikel lesen
22.04.Sequana Medical NV: Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025374Sequana Medical announces the Annual and Extraordinary General Meetings of Shareholders on 22 May 2025 Publication of Annual Report 2024 Ghent, Belgium - 22 April 2025 - Sequana Medical...
► Artikel lesen
14.04.CMS proposes approval of additional payment for Sequana Medical's Alfapump3
14.04.Sequana Medical NV: CMS Proposes Approval of Additional Payment for Sequana Medical's alfapump system in Hospital Inpatient Cases1.021CMS Proposes Approval of Additional Payment for Sequana Medical's alfapump® system in Hospital Inpatient Cases New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2026 Rule, expected...
► Artikel lesen
08.04.Sequana Medical NV: Sequana Medical Announces New Share Capital Amount And New Number Of Shares586SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 8 April 2025 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical")...
► Artikel lesen
27.03.Sequana Medical NV: Sequana Medical to Attend the "VFB Happening 2025" in Ghent, Belgium on Saturday, 29 March 2025420Sequana Medical to Attend the "VFB Happening 2025" in Ghent, Belgium on Saturday, 29 March 2025 Ghent, Belgium - 27 March 2025 - Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana...
► Artikel lesen
20.03.Sequana Medical NV: Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation498Sequana Medical to Sponsor Liver Connect, 5th Annual Conference of Chronic Liver Disease Foundation Ghent, Belgium - 20 March 2025 - Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or...
► Artikel lesen
19.03.Sequana Medical NV GAAP EPS of -€1.22, revenue of €0.106M2
18.03.Sequana Medical NV: Sequana Medical announces 2024 Full Year Results and 2025 Outlook830Sequana Medical announces 2024 Full Year Results and 2025 Outlook alfapump® - US FDA approval of alfapump® for the treatment of recurrent or refractory ascites due to liver cirrhosis; US commercial...
► Artikel lesen
18.03.Sequana Medical NV: Sequana Medical Obtains Convertible Financing of EUR 4.0 Million from Major Shareholders and Committed Share Subscription Facility of up to EUR 60 Million from GEM447Sequana Medical Obtains Convertible Financing of EUR 4.0 Million from Major Shareholders and Committed Share Subscription Facility of up to EUR 60 Million from GEM Continued support from major shareholders...
► Artikel lesen
Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1